MARKET

CLNN

CLNN

Clene
NASDAQ
4.300
+0.090
+2.14%
After Hours: 4.234 -0.066 -1.53% 19:30 09/25 EDT
OPEN
4.150
PREV CLOSE
4.210
HIGH
4.490
LOW
4.120
VOLUME
136.46K
TURNOVER
--
52 WEEK HIGH
13.50
52 WEEK LOW
3.250
MARKET CAP
61.12M
P/E (TTM)
-1.2329
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CLNN last week (0914-0918)?
Weekly Report · 5d ago
Clene announces insider-led $4 million financing round
TipRanks · 09/16 21:27
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 09/15 17:06
Clene Announces $4M Registered Direct Offering; Funding Expected Through Q1 2027
NASDAQ · 09/15 13:14
Clene prices 1.22M shares at $3.28 in registered direct offering
TipRanks · 09/15 13:10
Clene Prices Registered Direct Offering Of 1,219,513 Shares At $3.28/Shr To Existing Shareholders With Total Gross Proceeds Of $4M
Benzinga · 09/15 13:01
Press Release: Clene Announces $4 Million Registered Direct Offering
Dow Jones · 09/15 13:00
Weekly Report: what happened at CLNN last week (0907-0911)?
Weekly Report · 09/14 09:17
More
About CLNN
Clene Inc. is a clinical-stage pharmaceutical company, which is engaged in discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The CSN therapeutics are comprised of atoms of transition elements that, when assembled in nanocrystal form, possess unusually high, unique catalytic activities that do not present in those same elements in bulk form. CNM-Au8, the lead drug asset, is a concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals for the treatment of ALS, MS, and PD. CNM-Au8's mechanism of action targets mitochondrial dysfunction by catalyzing the production of nicotinamide adenine dinucleotide. Its CNM-ZnAg is an antiviral and antibacterial agent comprised of zinc (Zn2+) and silver (Ag+) ions in an aqueous solution to treat infectious disease and to provide immune support for symptom resolution.

Webull offers Clene Inc stock information, including NASDAQ: CLNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CLNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CLNN stock methods without spending real money on the virtual paper trading platform.